Renasant Bio

Berkeley, CA · Founded 2022 · Privately Held (backing)

Operator of a biopharmaceutical research platform intended to develop oral small-molecule therapies for genetic kidney disorders. Renasant Bio is based in Berkeley, CA and was founded in 2022. It was valued at $78 million at its seed round in Jun 2025, the last priced event on record. It has raised $55.5 million across 2 recorded rounds; the latest was a $30 million early-stage round in Jun 2025.

PMV mark · valuation
$78.0M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$55.5M
Last round
Early Stage VC
Jun 2025
How much has Renasant Bio raised?
$55.5Macross 2 recorded rounds · Jul 2024 – Jun 2025

Most recently, Renasant Bio raised $30.0M in its Early Stage VC (Jun 2025).

Free account
More of Renasant Bio with a free account
  • ·Watch Renasant Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Renasant Bio round by round

2 rounds
Jun 2025Early Stage VC$30.0MSEC filing▮
4 investors participated
Jul 2024Early Stage VC$25.5MSEC filing▮
3 investors participated

How much has Renasant Bio raised?

Renasant Bio has raised $55.5 million across 2 recorded rounds since 2024. The largest was a $30 million early-stage round in Jun 2025.

Renasant Bio has filed 2 Form Ds with the SEC, most recently in Jul 2025 ($25.5 million sold to 3 investors).

Renasant Bio investors

5 investors are on record for Renasant Bio, including Qiming Venture Partners USA, OrbiMed, Atlas Venture and 5AM Ventures. The early-stage round in Jun 2025 drew 4 investors.

For fundraisers
Raising for a company like Renasant Bio?

5 investors have backed Renasant Bio.

See all 5 investors →

Frequently asked about Renasant Bio

How much has Renasant Bio raised?
Renasant Bio has raised $55.5M in total across 2 recorded funding rounds.
When was Renasant Bio's last funding round?
Renasant Bio's most recent recorded round was Early Stage VC in Jun 2025, raising $30.0M.